SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000947871-17-000867
Filing Date
2017-11-01
Accepted
2017-11-01 16:22:23
Documents
2
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ss65486_3.html 3  
1 OWNERSHIP DOCUMENT ss65486_3.xml 3 1606
2 POWER OF ATTORNEY ss65486_ex2401.htm EX-24.1 7903
  Complete submission text file 0000947871-17-000867.txt   10880
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Oncobiologics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ZAHRAN STREET, 7TH CIRCLE ZAHRAN PLAZA 4TH FLOOR, PO BOX 142904 AMMAN M2 11844
Business Address
Haddadin Yezan Munther (Reporting) CIK: 0001718004 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37759 | Film No.: 171169239